Immobazyme is a South African biotechnology company pioneering affordable, high-performance biologics for the cellular agriculture industry. Spun out of Stellenbosch University, the company utilises a proprietary precision fermentation platform to engineer food-grade, allergen-free recombinant growth factors - including FGF-2, IGF-1, and TGF-β - critical for serum-free cultivation. By leveraging advanced protein engineering and enzyme immobilisation technology, Immobazyme produces scalable, animal-free ingredients that enable cultivated meat producers to overcome cost barriers and transition from R&D to commercial manufacturing.